Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 12,416.00
Ask: 12,418.00
Change: 44.00 (0.36%)
Spread: 2.00 (0.016%)
Open: 12,330.00
High: 12,450.00
Low: 12,316.00
Prev. Close: 12,360.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

G7 to donate 1 billion COVID-19 vaccine doses to poorer countries

Thu, 10th Jun 2021 22:30

By Kate Holton

CARBIS BAY, England, June 10 (Reuters) - British Prime
Minister Boris Johnson expects the Group of Seven to agree to
donate 1 billion COVID-19 vaccine doses to poorer countries
during its summit starting on Friday, and help innoculate the
world by the end of next year.

Just hours after U.S. President Joe Biden vowed to
supercharge the battle against the coronavirus with a donation
of 500 million Pfizer shots, Johnson said Britain would
give at least 100 million surplus vaccines to the poorest
nations.

Johnson has already called on G7 leaders to commit to
vaccinate the entire world by the end of 2022 and the group is
expected to pledge 1 billion doses during its three-day summit
in the English seaside resort of Carbis Bay.

Some campaign groups condemned the plan as a drop in the
ocean, with Oxfam estimating that nearly 4 billion people will
depend on COVAX for vaccines, the programme that distributes
COVID-19 shots to low and middle income countries.

"As a result of the success of the UK's vaccine programme we
are now in a position to share some of our surplus doses with
those who need them," Johnson will say on Friday, according to
excerpts of the announcement released by his office.

"In doing so we will take a massive step towards beating
this pandemic for good."

COVID-19 has killed around 3.9 million people and ripped
through the global economy, with infections reported in more
than 210 countries and territories since the first cases were
identified in China in December 2019.

While scientists have brought vaccines to market at
breakneck speeds - Britain has given a first dose to 77% of its
adult population and the United States 64% - they say the
pandemic will only end once all countries have been vaccinated.

With a global population nearing 8 billion and most people
needing two doses, if not booster shots to tackle variants as
well, campaigners said the commitments marked a start but world
leaders needed to go much further, and much faster.

"The G7's aim to provide 1 billion doses should be seen as
an absolute minimum, and the timeframe needs to speed up," said
Lis Wallace at anti-poverty campaign group ONE.

"We're in a race with this virus and the longer it's in the
lead the greater the risk of new, more dangerous variants
undermining global progress."

Of the 100 million British shots, 80 million will go to the
COVAX programme led by the World Health Organization (WHO) and
the rest will be shared bilaterally with countries in need.

Johnson echoed Biden in calling on his fellow leaders to
make similar pledges and for pharmaceutical companies to adopt
the Oxford-AstraZeneca model of providing vaccines at cost for
the duration of the pandemic.

Leaving poorer countries to deal with the pandemic alone
risks allowing the virus to further mutate and evade vaccines.
Charities have also said that logistical support will be needed
to help administer large numbers of vaccines in poorer
countries.

The British doses will be drawn from the stock it has
already procured for its domestic programme, and will come from
suppliers Oxford-AstraZeneca, Pfizer-BioNTech,
Janssen, Moderna and others.

(Reporting by Kate Holton; editing by Guy Faulconbridge and
Grant McCool)

More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.